BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 53892)

  • 1. Blood changes in atherosclerosis and long after myocardial infarction and venous thrombosis.
    O'Brien JR; Etherington MD; Jamieson S; Lawford P; Lincoln SV; Alkjaersig NJ
    Thromb Diath Haemorrh; 1975 Nov; 34(2):483-97. PubMed ID: 53892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-thormbin III and heparin clotting times in thrombosis and atherosclerosis.
    O'Brien JR
    Thromb Diath Haemorrh; 1974 Sep; 32(1):116-23. PubMed ID: 4454034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet function in acute myocardial infarction patients compared with controls.
    O'Brien JR; Etherington MD; Shuttleworth RD; Calwell WH
    Thromb Haemost; 1980 Oct; 44(2):96-9. PubMed ID: 7455998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tests for hemostasis and their relevance to venous thrombosis.
    Johnston DW; Scott AA; Glynn MF
    Can J Surg; 1980 Jul; 23(4):373-80. PubMed ID: 6968239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Soluble P-selectin - a marker of platelet activation and vessel wall injury: increase of soluble P-selectin in plasma of patients with myocardial infarction, massive atherosclerosis and primary pulmonary hypertension].
    Semenov AV; Kogan-Ponomarev MIa; Ruda MIa; Komarov AL; Panchenko EP; Chazova IE; Mazurov AV
    Ter Arkh; 2000; 72(4):15-20. PubMed ID: 10833791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetic and functional studies of platelets, fibrinogen, and plasminogen in patients with hepatic cirrhosis.
    Stein SF; Harker LA
    J Lab Clin Med; 1982 Feb; 99(2):217-30. PubMed ID: 7061918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Rehabilitation in myocardial infarct. Study of various coagulation parameters and platelet function].
    Gibelli A; Fiorini GF; Renoldi P; Schweiger C; Piazza A; Paracchini ML
    Minerva Med; 1983 May; 74(21):1279-84. PubMed ID: 6190108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemostatic effects of oral contraceptives in women who developed deep-vein thrombosis while using oral contraceptives.
    Bloemenkamp KW; Rosendaal FR; Helmerhorst FM; Koster T; Bertina RM; Vandenbroucke JP
    Thromb Haemost; 1998 Sep; 80(3):382-7. PubMed ID: 9759614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemostatic variables and the outcome of myocardial infarction.
    Haines AP; Howarth D; North WR; Goldenberg E; Stirling Y; Meade TW; Raftery EB; Millar Craig MW
    Thromb Haemost; 1983 Dec; 50(4):800-3. PubMed ID: 6198743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Protein C dynamics in peripheral arterial occlusive diseases and myocardial infarction: association of homozygous protein C deficiency with heterozygous dysplasminogenemia found among patients with deep vein thrombosis].
    Manabe S
    Nihon Geka Gakkai Zasshi; 1986 Feb; 87(2):220-30. PubMed ID: 3754930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the significance of antithrombin-III, alpha 2-macroglobulin, alpha 2-antiplasmin, histidine-rich glycoprotein, and protein C in patients with acute myocardial infarction and deep vein thrombosis.
    Gram J; Jespersen J
    Thromb Haemost; 1985 Aug; 54(2):503-5. PubMed ID: 2417353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiphospholipid antibodies, haemostatic variables and thrombosis--a survey of 144 patients.
    Ames PR; Pyke S; Iannaccone L; Brancaccio V
    Thromb Haemost; 1995 May; 73(5):768-73. PubMed ID: 7482401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fibrinolytic system in patients with myocardial infarction and other coronary disease risk factors].
    Moreno JA; Gálvez MM; Cornudella R; Angós JA; Romero MS; Gutiérrez M
    Sangre (Barc); 1994 Apr; 39(2):111-6. PubMed ID: 8059288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet survival studies in man. With special reference to thrombosis and atherosclerosis.
    Abrahamsen AF
    Scand J Haematol Suppl; 1968; 3():1-53. PubMed ID: 5253463
    [No Abstract]   [Full Text] [Related]  

  • 15. [Relation of an increase of von Willebrand factor in the blood, acute myocardial infarction, unstable angina and coronary thrombosis].
    Mossard JM; Wiesel ML; Cazenave JP; Grunebaum L; Drawin T; Kieny JR; Roul G; Bareiss P; Sacrez A
    Arch Mal Coeur Vaiss; 1989 Nov; 82(11):1813-8. PubMed ID: 2514633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P-selectin and antibodies against heparin-platelet factor 4 in patients with venous or arterial diseases after a 7-day heparin treatment.
    Papalambros E; Sigala F; Travlou A; Bastounis E; Mirilas P
    J Am Coll Surg; 2004 Jul; 199(1):69-77. PubMed ID: 15217633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of blood coagulation tests in deep venous thrombosis.
    Okrucká A; Pechán J
    Mater Med Pol; 1992; 24(4):256-9. PubMed ID: 1308056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intra-platelet platelet factor 4 (IP.PF4) and the heparin-mobilisable pool of PF4 in health and atherosclerosis.
    O'Brien JR; Etherington MD; Pashley M
    Thromb Haemost; 1984 Jul; 51(3):354-7. PubMed ID: 6495255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
    Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
    Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood viscosity and thrombosis: clinical considerations.
    Smith BD; La Celle PL
    Prog Hemost Thromb; 1982; 6():179-201. PubMed ID: 6762612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.